The COVID-19 vaccine produced by pharmaceutical giant Pfizer was recently approved by both the FDA (the US's Food and Drug Administration) and Health Canada and is being rolled out throughout the USA and Canada  to fight the pandemic.

Pfizer and the US and Canadian  governments have agreed on the shipment of several  million frozen doses to reach all areas of each country.

Market leader in the end-of-line packaging sector and technology partner to Pfizer, Italy’s Robopac will be guaranteeing the vaccine's packaging and transport safety following its contribution to the development of ad hoc solutions for the packaging of pharmaceutical products made by the American giant.

Robopac's Ecoplat Plus is the solution adopted by Pfizer for packaging the vaccine doses being distributed in the USA and Canada.

A significant achievement for everyone, in which Robopac - once again - has played a leading role in an industrial venture with great humanitarian importance.

Source: Robopac